Home -
Products -
Proteasome/Ubiquitin -
Endogenous Metabolite -
1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
CAS No. 35418-59-8
1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine( —— )
Catalog No. M26016 CAS No. 35418-59-8
1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine is an endogenous metabolite.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 298 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 806 | Get Quote |
|
| 50MG | 1211 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
-
NoteResearch use only, not for human use.
-
Brief Description1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine is an endogenous metabolite.
-
Description1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphocholine is an endogenous metabolite.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorPEGs
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number35418-59-8
-
Formula Weight810.151
-
Molecular FormulaC46H84NO8P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
3,4,5-Trimethoxyphen...
3,4,5-TrimethoxyphenyL, an intermediate metabolite of mescaline, is oxidized from the oxidation of 3,4,5-Trimethoxyphenylacetaldehyde by mouse hepatic microsomes.
-
L-Methionine
L-Methionine is the L-isomer of Methionine an essential amino acid for human development. Methionine acts as a hepatoprotectant.
-
Glucagon-Like Peptid...
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a potential therapeutic agent for the human subjects with a broad variety of intestinal diseases characterized by intestinal damage and insufficiency.
Cart
sales@molnova.com